The United States Patent and Trademark Office July 19, 2005 The National Association of Patent Practitioners 2005 Patent Practice Update.

Slides:



Advertisements
Similar presentations
Speeding It Up at the USPTO
Advertisements

Daphne C. Lainson Smart & Biggar/Fetherstonhaugh Overview of USPTO Patent Statistics.
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
Accelerating Patent Prosecution Thursday, October 18, 2012.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
Appeal Practice Before Board of Patent Appeals and Interferences
CIPA Update. FOR SCHOOLS – By July 1, 2012, amend your existing Internet safety policy (if you have not already done so) to provide for the education.
1 Patent Operations: Updates & Highlights Austin Intellectual Property Law Association Austin, TX March 23, 2010.
Accelerated Examination Bennett Celsa (TC 1600: QAS)
Proposed Rule Changes to Focus the Patent Process Involving Continuations, Double Patenting and Claims Connecticut Intellectual Property Law Association.
Application Filings and Examiner Production. UPR Applications Filed
The United States Patent and Trademark Office March 15, 2005 BCP Customer Partnership Meeting.
THE STATE OF THE PATENT SYSTEM BACKGROUND FOR RULE PROPOSALS Los Angeles Intellectual Property Law Association “Washington and the West” Conference January.
John Doll – Commissioner for Patents February 1, 2006.
Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)
Green Technology Petition Pilot Robert W. Bahr. 2 Green Tech: Discussion Points 1. Authority and Overview: resources / overview 2.Petition Requirement:
Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy.
Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.
General Information on Patents and the Patent Process presented to North American Association of State and Provincial Lotteries June 24, 2008 Brian Hanlon,
John Doll Commissioner for Patents. 2 USPTO Request for Public Input: Strategic Planning  Agency developing new strategic plan  Part of budget process.
Full First Action Interview (FFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
July 18, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818/P.L ) Topic: Patent Fees Office of Patent Legal.
Information Disclosure Statements
Charles R. Eloshway Patent Attorney Office of International Relations U.S. Patent and Trademark Office Conference on Intellectual Property in the Global.
Ashok K. Mannava Mannava & Kang, P.C. Expedited Examination Programs from the PTO February 12, 2012.
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
February 19, Recent Changes and Developments in USPTO Practice Prepared by: Office of Patent Legal Administration (OPLA) Robert J. Spar, DirectorJoni.
2 23,503 hours in FY 2013, compared with 21,273 hours in FY ,651 interview hours in FY 13 have been charged through the AFCP program. Interview.
Accelerated Examination Program Andrew Faile Director, TC 2600.
A View from Both Worlds: USPTO and the Federal Labs Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer National Institutes.
1 PPAC Patents Operations Update June 18th, 2009.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Customer Partnership Meeting John Doll Commissioner for Patents.
Our Divided Patent System John R. Allison University of Texas McCombs School of Business Mark A. Lemley Stanford Law School David L. Schwartz Northwestern.
1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.
1 Business Method Patents The USPTO Perspective Prepared for the Casualty Actuary Society Annual Meeting November 15, by John J. Love The United.
Christopher J. Fildes Fildes & Outland, P.C. Derivation Proceedings and Prior User Rights.
1 The CREATE Act and Other Interesting IP Tidbits Brian R. Stanton, Ph.D. Director, Division of Policy Office of Technology Transfer National Institutes.
USPTO Patent Quality Composite presented to Biotechnology/Chemical/Pharmaceutical Customer Partnership September 5, 2012 by Martin Rater Statistician USPTO,
Practice Before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
Claims and Continuations Final Rule Overview Briefing for Examiners 1.
USPTO Updated Strategic Plan in Brief March 3 rd, 2010.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
OCFO - Financial Status of USPTO May 7, FY 2010 Status Authorized level of $1,887.0 million Mid-year Budget Execution Review currently underway.
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Patent Fee Proposal Patent Public Advisory Committee Hearing November 19, 2015.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
Andrew B. Freistein Wenderoth, Lind & Ponack, L.L.P. Learning the ABC’s of Patent Term Adjustment 1 © AIPLA 2015.
“Welcome to the Table” May 15, 2006 Jay Lucas Deputy Commissioner for Patent Examination Policy.
First Action Interview Pilot Program Legal Secretaries & Administrators Conference June 18, 2009.
1. Video Conference Interviews 2 Sean Hagan Director of the Midwest Regional United States Patent and Trademark Office Webinar for Knobbe Martens January.
1 PPAC Patents Operations Update Peggy Focarino Deputy Commissioner for Patents July 8, 2010.
The United States Patent and Trademark Office January 27, 2005.
Board of Patent Appeals and Interferences May 15, Interference Practice Q&A James T. Moore Administrative Patent Judge
US Patent Application Drafting Center Presentation ppt Patent Stats That Can Help Your Practice Electronic & Computer Law Committee Manny Schecter.
Patents, Trade Secrets and Unfair Competition
Claims and Continuations Final Rule
PATENT LAW TREATY Gena Jones Senior Legal Advisor
Boston Patent Law Association
TC 1600 Biotechnology and Pharmaceutical Customer Partnership Meeting
First Action Interview Pilot Program
Los Angeles Intellectual Property Law Association
The National Association of Patent Practitioners (NAPP)
Boston Patent Law Association Annual Meeting
Presentation transcript:

The United States Patent and Trademark Office July 19, 2005 The National Association of Patent Practitioners 2005 Patent Practice Update

Contact Information John Doll Acting Commissioner for Patents & Deputy Commissioner for Patents Resources and Planning Phone:

... and Examiner Production Application Filings

FY 04 UPR Applications Filed FY 04 UPR 1 Applications Filed Technology Center FY 04 FY 03 to FY04 Growth Rate Biotechnology and Organic Chemistry38, % Chemical and Materials Engineering 49, % Computer Architecture Software and Information Security 34, % Communications48, % Semiconductor, Electrical, Optical Systems81,1447.6% Transportation, Construction, Electronic Commerce47, % Mechanical Engineering, Manufacturing and Products56,5335.5% UPR Total 355,5276.6% 1 “UPR” = Utility, Plant, and Reissue Applications

UPR Applications Filed   FY 05 plan 375,080 (~6% above FY 04)   255,411 as of 6/3/2005   Current projection 1.9% over plan

FY 04 FY 05 3 rd QTR FY 05 Target UPR 1 FAOM 2 288,315210,674297,614 UPR Disposals 3 287,188205,973295,456 UPR Production Units 4 287,752208,324296,535 PCT Production Units 5 16,88211,37222,916 Production 1 “ UPR” = Utility, Plant, and Reissue Applications. 2 “ FAOM” = First Action on the Merits – first action count by an examiner after the filing of an application (does not include restrictions or other miscellaneous actions). 3 “ Disposal” = An examiner allowance, abandonment, or disposals following a board decision. 4 “ Production Unit” = First action count plus disposal count divided by 2. 5 “ PCT” = Patent Cooperation Treaty. PCT applications are processed differently and tracked separately from US National stage applications. For FY 05, 11,372 PU’s is 26,417 processed applications.

PCT Applications Filed FY 043 rd QTR 043 rd QTR 05 International Applications Received* 45,39633,68635,400 Demands Filed19,89415,1357, Applications Filed37,17329,16229,630 * Currently 54% of Chapter 1 filings designate USPTO as Searching Authority, in FY 04 it was 60% * Demands down due to change to PCT practice permitting applicants to get to 30 months before filing national stage from Chapter 1 instead of having to file Chapter 2.

FY 2004 FY 2004 (3 rd QTR) FY 2005 (3 rd QTR) Search Reports17,9359,92612,788 International Preliminary Examination Reports (IPERs) 19,43913,2429,956* PCT Production * Number of IPERS down due to search and written opinion being available in the new form 237.

... vs the Backlog PENDENCY

FY 05 Patent Pendency (as of 7/1/2005) FY 05 Patent Pendency (as of 7/1/2005) Technology Center Average 1 st Action Pendency (months) 1 Average Total Pendency (months) Biotechnology and Organic Chemistry Chemical and Materials Engineering Computer Architecture Software and Information Security – Communications Semiconductor, Electrical, Optical Systems Transportation, Construction, Electronic Commerce Mechanical Engineering, Manufacturing and Products UPR Total (as of 7/1/2005) FY 05 Target 20.7* “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during 1 st quarter FY “Average total pendency” is the average age from filing to issue or abandonment of a newly filed application, completed during 1 st quarter FY * Assuming current input and output estimates, the agency should achieve first action pendency of 21.3 months by the end of FY 2005 and total pendency of 30.2 months.

First Action Pendency by Art Areas High Pendency Art Areas Pendency 1 (months) Low Pendency Art Areas Pendency 1 (months) 1630 – Molecular Biology, DNA/RNA, Gene Therapy, Nucleic Acid – Heterocyclic Compounds and Uses – Distillation, Mineral Oil and Hydrocarbons – Radiation Imagery – Simulation and Modeling, Emulation of Computer Components – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control – Interactive Video Distribution – General Electrical Communication – Control Circuits – Electrical Connectors – Health Care, Insurance – Animal and Plant Husbandry – Body Treatment, Kinestherapy, and Exercising – Thermal Combustion Technology “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during 3 rd quarter FY 2005.

Inventory by Art Examples High Inventory Art Areas Months of Inventory* Low Inventory Art Areas Months of Inventory* 1614, 1615, and 1617 – Drugs, Bio-affecting and Body Treatment 47 – – Organic Chemistry – Chemical Analysis – Adhesive Bonding and Coating Apparatus – Computer Task Management – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control – Interactive Video Distribution , 2653 – Information Storage and Retrieval – Control Circuits – Electrical Conductors – Business Methods34 – – Conveying and 3737 – Medical Instruments, Diagnostic Equipment 46 – – Thermal and Combustion Technology 10 * The number of months it would take to reach a first action on the merits (e.g., an action addressing patentability issues) on a new application filed as of Jan 2005 at today’s production rate. Today’s production rate means that there are no changes in production due to hiring, attrition, changes to examination processing or examination efficiencies, and that applications are taken up in the order of filing in the given art unit/area. Of course, USPTO is taking aggressive steps to ensure changes that will significantly lower the inventory rates in high-inventory art areas.

Total*Design New Applications 1 9/30/ ,40263,92371,77897,38077,65156,73865,005508,87818,451 New Applications 1 7/1/ ,10470,34675,400110,66391,58167,46680,028573,39122,958 Overall Pending Applications 2 9/30/ ,006105,447102,440138,822137,458101,097108,039809,32327,599 Overall Pending Applications 2 7/1/ ,066115,891115,398161,479154,333113,775126,124907,90135,432 TC Application Inventory 1 “ New Application inventory” is the number of new applications designated or assigned to a technology center awaiting a first action. 2 “ Overall Pending Application inventory” is the total number of applications designated or assigned to a technology center in an active status. Includes new applications; rejected awaiting response; amended; under appeal or interference; suspended; reexams and allowed applications awaiting grant publication. *Total inventory includes applications not assigned to a particular TC, awaiting processing either pre- or post-examination.

Patent Quality (Shared Responsibility)

Quality of Products – FY 04 Fiscal Year Design FY 04 Total FY 05 Target Patent In-Process Examination Compliance Rate %83.1%88.3%74.2%86.8%79.6%81.7%90.4%82.0%84.0% Patent Allowance Error Rate %8.03%3.05%2.53%3.39%7.54%9.01%3.28%5.32%4.0% 1 Compliance is the percent of office actions reviewed and found to be free of any in-process examination deficiency (an error that has significant adverse impact on patent prosecution). 2 Patent allowance error rate is the percent of allowed applications reviewed having at least one claim which is considered unpatentable on a basis for which a court would hold a patent invalid. “Allowance” occurs before a patent is issued, so these errors are caught before any patent is actually granted.

Quality of Products – FY 05 Third Quarter Fiscal Year Design 3 rd QTR FY 05 FY 05 Target Patent In-Process Examination Compliance Rate* 81.4%83.2%90.9%85.5%91.5%84.5%86.7%94.0%86.8%84.0% Patent Allowance Error Rate** 4.35%9.45%4.19%1.86%4.55%6.25%7.53%4.17%5.35%4.0% Compliance and error rates as measured by OPQA. *Compliance rates estimated by correcting for unresolved errors using reversal rate through 3 rd quarter of FY 05. TC compliance rates not finalized at this time. **Estimates based on unresolved errors and historical reversal rates.

UPR Patents Issued   FY ,637 FY 2005 through 6/28/ ,688   FY 2005 Plan 176,837

Re-Work

Technology Centers Rework* Statistics * Rework first actions are those actions that are in a Continuing, CPA or RCE application. ** As of May 21, 2005

Hiring and Retention

Hires and Attritions *Includes hires on board and confirmed and pending offers CorpsDesign FY 04 Hires FY 04 Attritions FY 05 BOY Examiner Staff FY 05 Hiring Summary (06/27/05)* FY 05 Attrits Summary (07/01/05) FY 05 Hiring Goal New Hires as a Percent of Examiner Staffing in the TC 24%8%36%23%22%21%29%23%28%

Pre-AppealConferences

Pre-Appeal Conference Background É 21 st Century Strategic Plan – Quality É Approximately 60% of all appealed cases are “not” forwarded to BPAI Action Plan É Review to determine whether Appeal is warranted July 12, 2005 OG Notice

Reexamination

Reexamination Background É 21 st Century Strategic Plan- Timely Process É Large number of pending reexams over four years Action Plan É Process ex parte reexam proceedings pending over 2 years by end of FY ‘05 É This will eliminate 420 of 1200 current proceedings

PETITION to MAKE SPECIAL and Accelerated Examination

Applications Eligible for Petition to Make Special Subject Matter Eligible for Expedited Examination  Counter Terrorism  HIV / AIDS / Cancer  Energy Resources  Environmental Quality  Recombinant DNA  Super-Conductivity  Small Entity Biotechnology Applications  Manufacturing Other Reasons to Expedite Examination  Applicant’s Age  Applicant’s Health  Infringement - Claimed Subject Matter  Accelerated Examination  Any application  With pre-examination search  With detailed explanation distinguishing references deemed must closely related to the claims  Propose 12 months to final disposition in FY 2006

Petition to Make Special (All Categories) Statistics

Petition to Make Special (All Categories) Petition Disposition

Processing Times for Petitions to Make Special (All Categories) As of July 14, Includes only those that have had a first action after the petition decision. As of July 14, Includes only those that have had a first action after the petition decision.

Accelerated Examination Current Version under Petition to Make Special Current Version under Petition to Make Special  MPEP VIII, 37 CFR Current provisions: Current provisions: A.Petition/Fee B.Single invention or election without traverse to grant C.Pre-exam search listing field of search D.One copy each reference deemed closest art (NPL, foreign) E.Distinguish references from the claims

Accelerated Examination Section VIII Petition Statistics

Accelerated Examination Section VIII Petition Disposition

Processing Times for Accelerated Examination Section VIII Petitions As of July 14, Includes only those that have had a first action after the petition decision. As of July 14, Includes only those that have had a first action after the petition decision.

Accelerated Examination Features of the proposed revision: Features of the proposed revision:  Move to the head of the line  Final Disposition within 12 months  e-file application and all follow on papers  Single Invention  Limited Number of Claims  Patentability Report  Possible Interview before 1 st Action  Shortened Statutory Period  Enforcement of special status in the Corps

Thank You !!! John Doll Acting Commissioner for Patents Office Phone: Direct Line: